Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapy

Hepatitis due to hepatitis B virus (HBV) reactivation can be severe and potentially fatal, but is preventable. HBV reactivation is most commonly reported in patients receiving cancer chemotherapy, especially rituximab-containing therapy for hematological malignancies and those receiving stem cell tr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World J Gastroenterol
Main Authors: Law, Man Fai, Ho, Rita, Cheung, Carmen K M, Tam, Lydia H P, Ma, Karen, So, Kent C Y, Ip, Bonaventure, So, Jacqueline, Lai, Jennifer, Ng, Joyce, Tam, Tommy H C
Formato: Artigo
Idioma:Inglês
Publicado em: Baishideng Publishing Group Inc 2016
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4968128/
https://ncbi.nlm.nih.gov/pubmed/27605883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v22.i28.6484
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados